BioCentury
ARTICLE | Company News

MediChem, Rigel deal

September 10, 2001 7:00 AM UTC

MCLS will express, purify, co-crystallize and provide three-dimensional structures for protein complexes that are part of RIGL's ubiquitin ligase cancer program. MCLS will receive research funding, mi...